A new study investigated the brain circuits involved in psychosis—a condition characterized by delusions, hallucinations, ...

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, outlines the progression of treatment approaches for comorbid ...

In a notable Genomic Press research report, researchers at the Aristotle University of Thessaloniki have uncovered a ...

Upward telemedicine trends in schizophrenia treatment were rapid after the COVID-19 pandemic, particularly in state-operated agencies.

Even under the best of circumstances, remembering to take a daily pill can be a challenge. For someone living with ...

Convulsive therapies are an underappreciated treatment that can alleviate symptoms of severe psychiatric disorders through rapid cycles of muscle contraction ...

The following is a summary of “Circulating Levels of Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Schizophrenia: a systematic review and meta-analysis,” published in the January 2025 issue of ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

The families of the victims of Valdo Calocane who killed Irish woman Grace O'Malley-Kumar as well as Barnaby Webber and Ian ...

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, discusses the bidirectional relationship between schizophrenia and ...

New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.

Research from Aristotle University of Thessaloniki, Greece reveals that over 26% of stable patients with schizophrenia ...